Ravuconazole

Ravuconazole (BMS-207147; ER-30346) is an orally available triazole antifungle agent that potently inhibits a wide range of fungi.

Product Specifications

CAS Number

[182760-06-1]

Product Name Alternative

BMS-207147; ER-30346

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

Fungal

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection; Cancer

Assay Protocol

https://www.medchemexpress.com/Ravuconazole.html

Purity

99.91

Solubility

DMSO : ≥ 50 mg/mL

Smiles

FC1=CC(F)=CC=C1[C@](CN2C=NC=N2)(O)[C@@H](C)C3=NC(C4=CC=C(C#N)C=C4)=CS3

Molecular Formula

C22H17F2N5OS

Molecular Weight

437.47

Precautions

H315, H319, H335

References & Citations

[1]Hata K, et al. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.Antimicrob Agents Chemother. 1996 Oct;40 (10) :2237-42.|[2]Fung-Tomc JC, et al. In vitro activity of a new oral triazole, BMS-207147 (ER-30346) Antimicrob Agents Chemother. 1998 Feb;42 (2) :313-8.|[3]Hata K, et al. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.Antimicrob Agents Chemother. 1996 Oct;40 (10) :2243-7.